Sustainability

In an era where precision medicine is becoming increasingly relevant, the integration of digital technologies in clinical trials has emerged as a critical advancement that is reshaping the landscape of clinical research and development (R&D). The transformative role of technology in clinical

Mirror bacteria, theoretical organisms composed of chiral molecules that are mirror images of those found in natural life forms, have sparked significant debate within the scientific community. These organisms hinge on the concept of chirality, where "right-handed" amino acids and

MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of

The pharmaceutical industry is currently experiencing a transformative period marked by evolving clinical trial dynamics, increased R&D investment, and significant post-pandemic adjustments. This transformation is primarily driven by the complexities of modern trials, the demands for

The Europe Plant Cell Culture Equipment Market is poised for significant growth from 2024 to 2031. This article delves into the various facets of this burgeoning market, providing a comprehensive analysis that includes market dynamics, product segmentation, regional insights, competitive landscape,

Synthetic biology represents a revolutionary discipline that applies engineering principles to biology, aiming to develop cells into sophisticated micro-factories capable of producing essential materials. With the potential to spearhead advancements across numerous industries—including medicine, a